{"id":"https://openalex.org/W2500446408","doi":"https://doi.org/10.1158/1538-7445.am2016-2690","title":"Abstract 2690: A novel antibody-drug conjugate directed to the ALK receptor tyrosine kinase demonstrates efficacy in models of neuroblastoma","display_name":"Abstract 2690: A novel antibody-drug conjugate directed to the ALK receptor tyrosine kinase demonstrates efficacy in models of neuroblastoma","publication_year":2016,"publication_date":"2016-07-15","ids":{"openalex":"https://openalex.org/W2500446408","doi":"https://doi.org/10.1158/1538-7445.am2016-2690","mag":"2500446408"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2016-2690","doi":"https://doi.org/10.1158/1538-7445.am2016-2690","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-2690","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102864493","display_name":"Renata Sano","orcid":"https://orcid.org/0000-0001-9630-3388","observed_orcids":["https://orcid.org/0000-0001-9630-3388"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1335321130"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Renata Sano","raw_affiliation_strings":["1Children's Hospital of Philadelphia, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Children's Hospital of Philadelphia, Philadelphia, PA;","institution_ids":["https://openalex.org/I1335321130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053226567","display_name":"Kateryna Krytska","orcid":"https://orcid.org/0009-0009-8402-8687","observed_orcids":["https://orcid.org/0009-0009-8402-8687"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1335321130"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kateryna Krytska","raw_affiliation_strings":["1Children's Hospital of Philadelphia, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Children's Hospital of Philadelphia, Philadelphia, PA;","institution_ids":["https://openalex.org/I1335321130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020775465","display_name":"Colleen Larmour","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1335321130"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colleen Larmour","raw_affiliation_strings":["1Children's Hospital of Philadelphia, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Children's Hospital of Philadelphia, Philadelphia, PA;","institution_ids":["https://openalex.org/I1335321130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075656429","display_name":"Gwenda F. Ligon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gwenda F. Ligon","raw_affiliation_strings":["2Kolltan Pharmaceuticals, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Kolltan Pharmaceuticals, New Haven, CT;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016156079","display_name":"Jay S. Lillquist","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jay S. Lillquist","raw_affiliation_strings":["2Kolltan Pharmaceuticals, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Kolltan Pharmaceuticals, New Haven, CT;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049953201","display_name":"Ulisse Cucchi","orcid":"https://orcid.org/0009-0003-7487-2581","observed_orcids":["https://orcid.org/0009-0003-7487-2581"]},"institutions":[{"id":"https://openalex.org/I4210127540","display_name":"Nerviano Medical Sciences","ror":"https://ror.org/038mzt421","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210127540"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ulisse Cucchi","raw_affiliation_strings":["3Nerviano Medical Sciences, Nerviano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Nerviano Medical Sciences, Nerviano, Italy","institution_ids":["https://openalex.org/I4210127540"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025261960","display_name":"Paolo Orsini","orcid":"https://orcid.org/0009-0000-8427-0945","observed_orcids":["https://orcid.org/0009-0000-8427-0945"]},"institutions":[{"id":"https://openalex.org/I4210127540","display_name":"Nerviano Medical Sciences","ror":"https://ror.org/038mzt421","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210127540"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paolo Orsini","raw_affiliation_strings":["3Nerviano Medical Sciences, Nerviano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Nerviano Medical Sciences, Nerviano, Italy","institution_ids":["https://openalex.org/I4210127540"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087080299","display_name":"Simona Rizzi","orcid":"https://orcid.org/0000-0002-1515-2096","observed_orcids":["https://orcid.org/0000-0002-1515-2096"]},"institutions":[{"id":"https://openalex.org/I4210127540","display_name":"Nerviano Medical Sciences","ror":"https://ror.org/038mzt421","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210127540"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Simona Rizzi","raw_affiliation_strings":["3Nerviano Medical Sciences, Nerviano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Nerviano Medical Sciences, Nerviano, Italy","institution_ids":["https://openalex.org/I4210127540"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069477348","display_name":"Gerald McMahon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerald McMahon","raw_affiliation_strings":["2Kolltan Pharmaceuticals, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Kolltan Pharmaceuticals, New Haven, CT;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028465682","display_name":"Diego Alvarado","orcid":"https://orcid.org/0000-0002-5878-1730","observed_orcids":["https://orcid.org/0000-0002-5878-1730"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diego Alvarado","raw_affiliation_strings":["2Kolltan Pharmaceuticals, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Kolltan Pharmaceuticals, New Haven, CT;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030496565","display_name":"Ya\u00ebl P. Moss\u00e9","orcid":"https://orcid.org/0000-0002-3463-0399","observed_orcids":["https://orcid.org/0000-0002-3463-0399"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1335321130"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yael P. Mosse","raw_affiliation_strings":["1Children's Hospital of Philadelphia, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Children's Hospital of Philadelphia, Philadelphia, PA;","institution_ids":["https://openalex.org/I1335321130"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"76","issue":"14_Supplement","first_page":"2690","last_page":"2690"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9829999804496765},{"id":"https://openalex.org/keywords/alk-receptor-tyrosine-kinase","display_name":"ALK receptor tyrosine kinase","score":0.9589999914169312},{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.9789999723434448},{"id":"https://openalex.org/keywords/alk-inhibitors","display_name":"ALK inhibitors","score":0.531000018119812},{"id":"https://openalex.org/keywords/tumor-antigens","display_name":"tumor antigens","score":0.5460000038146973},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8859999775886536},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.6449999809265137},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.6919999718666077},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.5440000295639038},{"id":"https://openalex.org/keywords/high-risk-neuroblastoma","display_name":"high-risk neuroblastoma","score":0.7020000219345093},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.6290000081062317}],"concepts":[{"id":"https://openalex.org/C2776715637","wikidata":"https://www.wikidata.org/wiki/Q938205","display_name":"Neuroblastoma","level":3,"score":0.8960555791854858},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6655417680740356},{"id":"https://openalex.org/C117643217","wikidata":"https://www.wikidata.org/wiki/Q17824987","display_name":"Anaplastic lymphoma kinase","level":4,"score":0.6226049661636353},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.6137290596961975},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5540133714675903},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5334572792053223},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5281776785850525},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.46995973587036133},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.43968698382377625},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.438772976398468},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.43017423152923584},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.4203019142150879},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.4122856557369232},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4090813398361206},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.37681862711906433},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3624381721019745},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.3333476781845093},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30194222927093506},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2867918908596039},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.27165383100509644},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.22550740838050842},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1881202757358551},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11784300208091736},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11283800005912781},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09133696556091309},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.08344033360481262},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2016-2690","doi":"https://doi.org/10.1158/1538-7445.am2016-2690","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-2690","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2922363031","https://openalex.org/W2040159743","https://openalex.org/W2155440541","https://openalex.org/W2316697874","https://openalex.org/W4236706429","https://openalex.org/W4282981083","https://openalex.org/W4393093036","https://openalex.org/W4308375768","https://openalex.org/W4389190046","https://openalex.org/W3180382995"],"abstract_inverted_index":{"Abstract":[0],"Activated":[1],"ALK":[2,29,36,78,130,163,194,226,280,340],"by":[3],"mutation":[4,170,195],"or":[5,73],"amplification":[6],"is":[7,37],"a":[8,13,57,99,110,151,205,216,267,298],"validated":[9],"therapeutic":[10,177,301],"target":[11],"in":[12,68,74,109,142,181,208,238,253,266,346],"subset":[14],"of":[15,42,45,56,112,168,179,233,263,270,286,294,348,353,358],"patients":[16,303],"with":[17,76,162,247,278,304],"high-risk":[18],"neuroblastoma,":[19],"and":[20,103,125,136,165,215,289],"tyrosine":[21,342],"kinase":[22,85,343],"inhibitors":[23,79],"are":[24,256],"being":[25],"developed":[26],"to":[27,98,154,174,199,204,212,224,235,243,258,338],"abrogate":[28],"signaling":[30],"(Bresler":[31],"et":[32],"al,":[33],"2014).":[34],"Native":[35],"expressed":[38],"on":[39,50],"the":[40,43,176,190,239,260,264,339,354,359],"surface":[41,129],"majority":[44],"neuroblastoma":[46,69,116,155,272],"tumors,":[47,188],"but":[48],"not":[49],"normal":[51],"tissue,":[52],"giving":[53],"it":[54],"properties":[55],"tumor":[58,209],"antigen.":[59],"We":[60],"hypothesized":[61],"that":[62,160,201],"ALK-targeted":[63],"antibodies":[64],"may":[65],"be":[66,244],"useful":[67],"as":[70,227,229,297],"single-agent":[71],"immunotherapy":[72],"combination":[75],"small-molecule":[77],"-":[80],"especially":[81],"where":[82],"mutations":[83],"reduce":[84],"inhibitor":[86],"sensitivity.":[87],"In":[88,172],"this":[89,295],"work,":[90],"an":[91,279],"anti-ALK":[92],"monoclonal":[93],"antibody":[94,214],"(anti-ALK2)":[95],"was":[96,107,131,148,166],"conjugated":[97],"cytotoxic":[100],"agent":[101],"(ALK2-ADC)":[102],"its":[104],"anti-tumor":[105],"activity":[106],"investigated":[108],"panel":[111],"extensively":[113],"characterized":[114],"human":[115,230,276],"cell":[117],"lines":[118],"(n":[119],"=":[120],"10)":[121],"harboring":[122],"wild":[123],"type":[124],"mutant":[126],"ALK.":[127],"Cell":[128],"quantified":[132],"using":[133],"flow":[134],"cytometry":[135],"revealed":[137],"differential":[138],"antigen":[139],"expression.":[140],"Using":[141],"vitro":[143],"growth":[144,210],"inhibition":[145],"assays,":[146],"there":[147],"evidence":[149],"for":[150,302,362],"dose-dependent":[152],"cytotoxicity":[153],"cells":[156],"at":[157],"subnanomolar":[158],"concentrations":[159],"correlated":[161],"expression":[164],"independent":[167],"underlying":[169],"status.":[171],"order":[173],"evaluate":[175],"potential":[178,262,299],"ALK2-ADC":[180,202,221],"vivo,":[182],"mice":[183],"bearing":[184],"Felix-patient-derived":[185],"xenograft":[186],"(PDX)":[187],"containing":[189],"third":[191],"most":[192],"common":[193],"(R1245C),":[196],"were":[197],"used":[198],"demonstrate":[200],"led":[203],"significant":[206],"reduction":[207],"compared":[211],"unconjugated":[213],"control":[217],"ADC":[218,265],"(p<0.0001).":[219],"Although":[220],"binds":[222],"potently":[223],"mouse":[225],"well":[228,245],"ALK,":[231],"doses":[232],"up":[234],"10":[236],"mg/kg":[237],"rodent":[240],"model":[241],"appeared":[242],"tolerated":[246],"no":[248],"overt":[249],"toxicity":[250],"noted.":[251],"Additional":[252],"vivo":[254],"studies":[255],"ongoing":[257],"assess":[259],"antitumor":[261],"broader":[268],"range":[269],"ALK-expressing":[271,277],"models.":[273],"Thus,":[274],"targeting":[275],"antibody-drug":[281,335],"conjugate":[282,336],"demonstrated":[283],"early":[284],"signs":[285],"favorable":[287],"efficacy":[288,345],"tolerability":[290],"supporting":[291],"future":[292],"development":[293],"approach":[296],"novel":[300,334],"neuroblastoma.":[305,349],"Citation":[306],"Format:":[307],"Renata":[308],"Sano,":[309],"Kateryna":[310],"Krytska,":[311],"Colleen":[312],"Larmour,":[313],"Gwenda":[314],"F.":[315],"Ligon,":[316],"Jay":[317],"S.":[318],"Lillquist,":[319],"Ulisse":[320],"Cucchi,":[321],"Paolo":[322],"Orsini,":[323],"Simona":[324],"Rizzi,":[325],"Gerald":[326],"McMahon,":[327],"Diego":[328],"Alvarado,":[329],"Yael":[330],"P.":[331],"Mosse.":[332],"A":[333],"directed":[337],"receptor":[341],"demonstrates":[344],"models":[347],"[abstract].":[350],"In:":[351],"Proceedings":[352],"107th":[355],"Annual":[356],"Meeting":[357],"American":[360],"Association":[361],"Cancer":[363,374],"Research;":[364],"2016":[365],"Apr":[366],"16-20;":[367],"New":[368],"Orleans,":[369],"LA.":[370],"Philadelphia":[371],"(PA):":[372],"AACR;":[373],"Res":[375],"2016;76(14":[376],"Suppl):Abstract":[377],"nr":[378],"2690.":[379]},"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-08-23T00:00:00"}